Science3 weeks ago
Citizens Jmp Initiates Coverage on Assembly Biosciences with Target Price of $38
On August 16, 2023, Citizens Jmp began coverage of Assembly Biosciences (NASDAQ: ASMB), assigning an “outperform” rating along with a target price of $38.00. This biopharmaceutical...
